Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 133

1.

Incidence of Y chromosome microdeletions in patients with Klinefelter syndrome.

Sciarra F, Pelloni M, Faja F, Pallotti F, Martino G, Radicioni AF, Lenzi A, Lombardo F, Paoli D.

J Endocrinol Invest. 2019 Jul;42(7):833-842. doi: 10.1007/s40618-018-0989-7. Epub 2018 Nov 29.

PMID:
30499012
2.

Corrigendum to "A New Neurocognitive Interpretation of Shoulder Position Sense during Reaching: Unexpected Competence in the Measurement of Extracorporeal Space".

Paolucci T, Zangrando F, Piccinini G, Sciarra F, Pallotta R, Mannocci A, La Torre G, Bini F, Marinozzi F, Gumina S, Padua L, Saraceni VM.

Biomed Res Int. 2018 Jan 9;2018:9104751. doi: 10.1155/2018/9104751. eCollection 2018.

3.

Ambra1 Shapes Hippocampal Inhibition/Excitation Balance: Role in Neurodevelopmental Disorders.

Nobili A, Krashia P, Cordella A, La Barbera L, Dell'Acqua MC, Caruso A, Pignataro A, Marino R, Sciarra F, Biamonte F, Scattoni ML, Ammassari-Teule M, Cecconi F, Berretta N, Keller F, Mercuri NB, D'Amelio M.

Mol Neurobiol. 2018 Oct;55(10):7921-7940. doi: 10.1007/s12035-018-0911-5. Epub 2018 Feb 27.

4.

A New Neurocognitive Interpretation of Shoulder Position Sense during Reaching: Unexpected Competence in the Measurement of Extracorporeal Space.

Paolucci T, Zangrando F, Piccinini G, Sciarra F, Pallotta R, Mannocci A, la Torre G, Bini F, Marinozzi F, Gumina S, Padua L, Saraceni VM.

Biomed Res Int. 2016;2016:9065495. doi: 10.1155/2016/9065495. Epub 2016 Dec 25. Erratum in: Biomed Res Int. 2018 Jan 9;2018:9104751.

5.

KNAT3/4/5-like class 2 KNOX transcription factors are involved in Medicago truncatula symbiotic nodule organ development.

Di Giacomo E, Laffont C, Sciarra F, Iannelli MA, Frugier F, Frugis G.

New Phytol. 2017 Jan;213(2):822-837. doi: 10.1111/nph.14146. Epub 2016 Sep 1.

6.

Ultrasound tissue characterization does not differentiate genotype, but indexes ejection fraction deterioration in becker muscular dystrophy.

Giglio V, Puddu PE, Holland MR, Camastra G, Ansalone G, Ricci E, Mela J, Sciarra F, Di Gennaro M.

Ultrasound Med Biol. 2014 Dec;40(12):2777-85. doi: 10.1016/j.ultrasmedbio.2014.06.011. Epub 2014 Oct 11.

PMID:
25308949
7.

Patterns of late gadolinium enhancement in Duchenne muscular dystrophy carriers.

Giglio V, Puddu PE, Camastra G, Sbarbati S, Della Sala SW, Ferlini A, Gualandi F, Ricci E, Sciarra F, Ansalone G, Di Gennaro M.

J Cardiovasc Magn Reson. 2014 Jul 9;16:45. doi: 10.1186/1532-429X-16-45.

8.

Feeding problems and malnutrition in spinal muscular atrophy type II.

Messina S, Pane M, De Rose P, Vasta I, Sorleti D, Aloysius A, Sciarra F, Mangiola F, Kinali M, Bertini E, Mercuri E.

Neuromuscul Disord. 2008 May;18(5):389-93. doi: 10.1016/j.nmd.2008.02.008. Epub 2008 Apr 16.

PMID:
18420410
9.

Long-term incidence of atrial fibrillation and flutter after transcatheter atrial septal defect closure in adults.

Giardini A, Donti A, Sciarra F, Bronzetti G, Mariucci E, Picchio FM.

Int J Cardiol. 2009 May 1;134(1):47-51. doi: 10.1016/j.ijcard.2008.02.003. Epub 2008 Apr 8.

PMID:
18396341
10.

Feeding problems and weight gain in Duchenne muscular dystrophy.

Pane M, Vasta I, Messina S, Sorleti D, Aloysius A, Sciarra F, Mangiola F, Kinali M, Ricci E, Mercuri E.

Eur J Paediatr Neurol. 2006 Sep-Nov;10(5-6):231-6. Epub 2006 Oct 10.

PMID:
17045498
11.

Insulin-like growth factor (IGF)-I, IGF-II and IGF type I receptor (IGFR-I) expression in prostatic cancer.

Cardillo MR, Monti S, Di Silverio F, Gentile V, Sciarra F, Toscano V.

Anticancer Res. 2003 Sep-Oct;23(5A):3825-35.

PMID:
14666684
12.

Mutational analysis of StAR gene in adrenal tumors.

Stigliano A, Caiola S, Siniscalchi E, Papini E, Crescenzi A, Monti S, Arnaldi G, Mantero F, Sciarra F, Toscano V.

Int J Cancer. 2002 Jan 20;97(3):357-60.

13.

Regional variations of insulin-like growth factor I (IGF-I), IGF-II, and receptor type I in benign prostatic hyperplasia tissue and their correlation with intraprostatic androgens.

Monti S, Di Silverio F, Iraci R, Martini C, Lanzara S, Falasca P, Poggi M, Stigliano A, Sciarra F, Toscano V.

J Clin Endocrinol Metab. 2001 Apr;86(4):1700-6.

PMID:
11297606
14.

Effects of triptorelin, a gonadotropin-releasing hormone agonist, on the human prostatic cell lines PC3 and LNCaP.

Ravenna L, Salvatori L, Morrone S, Lubrano C, Cardillo MR, Sciarra F, Frati L, Di Silverio F, Petrangeli E.

J Androl. 2000 Jul-Aug;21(4):549-57.

15.

Role of estrogens in human benign prostatic hyperplasia.

Sciarra F, Toscano V.

Arch Androl. 2000 May-Jun;44(3):213-20. Review.

PMID:
10864369
16.

Epidermal growth factor binding sites in human pituitary macroadenomas.

Jaffrain-Rea ML, Petrangeli E, Lubrano C, Minniti G, Di Stefano D, Sciarra F, Frati L, Tamburrano G, Cantore G, Gulino A.

J Endocrinol. 1998 Sep;158(3):425-33.

PMID:
9846172
17.

Androgen concentrations and their receptors in the periurethral region are higher than those of the subcapsular zone in benign prostatic hyperplasia (BPH).

Monti S, Di Silverio F, Toscano V, Martini C, Lanzara S, Varasano PA, Sciarra F.

J Androl. 1998 Jul-Aug;19(4):428-33.

18.

Insulin-like growth factor-I and -II in human benign prostatic hyperplasia: relationship with binding proteins 2 and 3 and androgens.

Monti S, Di Silverio F, Lanzara S, Varasano P, Martini C, Tosti-Croce C, Sciarra F.

Steroids. 1998 May-Jun;63(5-6):362-6.

PMID:
9618803
19.

Hyperandrogenism in the adolescent female.

Toscano V, Balducci R, Mangiantini A, Falasca P, Sciarra F.

Steroids. 1998 May-Jun;63(5-6):308-13.

PMID:
9618792
20.

Prevalent decrease of the EGF content in the periurethral zone of BPH tissue induced by treatment with finasteride or flutamide.

Monti S, Sciarra F, Adamo MV, Toscano V, Trotta MC, Martini C, Lanzara S, Silverio FD.

J Androl. 1997 Sep-Oct;18(5):488-94.

21.

Incidence of major coronary heart disease events: the experience of the Project "Community Control of Chronic Diseases".

Giampaoli S, Vescio MF, Dima F, Poce A, De Sanctis PC, Sciarra F, Menotti A.

G Ital Cardiol. 1997 Jul;27(7):669-73.

PMID:
9282286
22.

Change in cardiovascular risk factors during a 10-year community intervention program.

Giampaoli S, Poce A, Sciarra F, Lo Noce C, Dima F, Minoprio A, Santaquilani A, Caiola de Sanctis P, Volpe R, Menditto A, Menotti A, Urbinati GC.

Acta Cardiol. 1997;52(5):411-22.

PMID:
9428939
23.

A clinician looks at androgen resistance.

Balducci R, Ghirri P, Brown TR, Bradford S, Boldrini A, Boscherini B, Sciarra F, Toscano V.

Steroids. 1996 Apr;61(4):205-11. Review.

PMID:
8733002
24.

Gene methylation of oestrogen and epidermal growth factor receptors in neoplastic and perineoplastic breast tissues.

Petrangeli E, Lubrano C, Ravenna L, Vacca A, Cardillo MR, Salvatori L, Sciarra F, Frati L, Gulino A.

Br J Cancer. 1995 Oct;72(4):973-5.

25.

Sex steroids and epidermal growth factor in benign prostatic hyperplasia (BPH).

Sciarra F.

Ann N Y Acad Sci. 1995 Jun 12;761:66-78.

PMID:
7542859
26.

Androgenic and antiandrogenic control on epidermal growth factor, epidermal growth factor receptor, and androgen receptor expression in human prostate cancer cell line LNCaP.

Ravenna L, Lubrano C, Di Silverio F, Vacca A, Felli MP, Maroder M, D'Eramo G, Sciarra F, Frati L, Gulino A, et al.

Prostate. 1995 Jun;26(6):290-8.

PMID:
7784269
27.

Androgen-secreting adrenal tumors.

Sciarra F, Tosti-Croce C, Toscano V.

Minerva Endocrinol. 1995 Mar;20(1):63-8. Review.

PMID:
7651284
28.

Regional distribution of epidermal growth factor, testosterone and dihydrotestosterone in benign prostatic hyperplasia tissue.

Sciarra F, Monti S, Adamo MV, Palma E, Toscano V, d'Eramo G, di Silverio F.

Urol Res. 1995;23(6):387-90.

PMID:
8788277
29.

Cost effectiveness in the management of benign prostatic hyperplasia: Italian data.

Di Silverio F, D'Eramo G, Flammia GP, Sciarra A, Buscarini M, Mauro M, Sciarra F.

Minerva Urol Nefrol. 1994 Jun;46(2):93-9.

PMID:
7526475
30.

Two different pathogenetic mechanisms may play a role in acne and in hirsutism.

Toscano V, Balducci R, Bianchi P, Guglielmi R, Mangiantini A, Rossi FG, Colonna LM, Sciarra F.

Clin Endocrinol (Oxf). 1993 Nov;39(5):551-6.

PMID:
8252744
31.

Relationship between epidermal growth factor and its receptor in human benign prostatic hyperplasia.

Lubrano C, Toscano V, Petrangeli E, Spera G, Trotta MC, Rombolà N, Frati L, Di Silverio F, Sciarra F.

J Steroid Biochem Mol Biol. 1993 Oct;46(4):463-8.

PMID:
7692939
32.

Steroidal and non-steroidal factors in plasma sex hormone binding globulin regulation.

Toscano V, Balducci R, Bianchi P, Guglielmi R, Mangiantini A, Sciarra F.

J Steroid Biochem Mol Biol. 1992 Oct;43(5):431-7. Review.

PMID:
1390292
33.

Sex steroid hormones in the pathogenesis of chronic subdural haematoma.

Giuffrè R, Palma E, Liccardo G, Sciarra F, Pastore FS, Concolino G.

Neurochirurgia (Stuttg). 1992 Jul;35(4):103-7.

PMID:
1508287
34.

Immunoreactive EGF in human benign prostatic hyperplasia: relationships with androgen and estrogen receptors.

Lubrano C, Sciarra F, Spera G, Petrangeli E, Toscano V, Rombola N, Palleschi F, Palma E, Di Silverio F.

J Steroid Biochem Mol Biol. 1992 Mar;41(3-8):683-7.

PMID:
1373303
35.

Lack of linear relationship between hyperinsulinaemia and hyperandrogenism.

Toscano V, Bianchi P, Balducci R, Guglielmi R, Mangiantini A, Lubrano C, Sciarra F.

Clin Endocrinol (Oxf). 1992 Feb;36(2):197-202.

PMID:
1533185
36.

Plasma 19-hydroxy-androstenedione (19-OH-A) in essential hypertension.

Tosti-Croce C, Rinaldi R, Massaria M, Lomurno A, Felicioli T, Sciarra F.

Clin Exp Hypertens A. 1992;14(6):1083-94.

PMID:
1330385
37.

Evidence that Serenoa repens extract displays an antiestrogenic activity in prostatic tissue of benign prostatic hypertrophy patients.

Di Silverio F, D'Eramo G, Lubrano C, Flammia GP, Sciarra A, Palma E, Caponera M, Sciarra F.

Eur Urol. 1992;21(4):309-14.

PMID:
1281103
38.

Plasma catecholamine responses during a personalized physical stress as a dynamic characterization of essential hypertension.

Tosti-Croce C, Lucarelli C, Betto P, Floridi A, Rinaldi R, Salvati A, Taggi F, Sciarra F.

Physiol Behav. 1991 Apr;49(4):685-90.

PMID:
1881970
39.

Antiandrogens: clinical applications.

Sciarra F, Toscano V, Concolino G, Di Silverio F.

J Steroid Biochem Mol Biol. 1990 Nov 20;37(3):349-62.

PMID:
2147859
40.

Ovarian 17-ketosteroid reductase deficiency as a possible cause of polycystic ovarian disease.

Toscano V, Balducci R, Bianchi P, Mangiantini A, Sciarra F.

J Clin Endocrinol Metab. 1990 Aug;71(2):288-92.

PMID:
2166066
41.
42.

[Changes in R wave voltage during exercise: are they a sign of changes in ventricular volume or of myocardial ischemia?].

Ciavolella M, Schiariti M, Cerquetani E, Ciani C, Giannitti C, Scali D, Sciarra F, Schad N, Reale A.

Cardiologia. 1990 Jan;35(1):33-40. Italian.

PMID:
2376051
43.

Zoladex vs. Zoladex plus cyproterone acetate in the treatment of advanced prostatic cancer: a multicenter Italian study.

Di Silverio F, Serio M, D'Eramo G, Sciarra F.

Eur Urol. 1990;18 Suppl 3:54-61.

PMID:
2151278
44.

Incidental prostatic carcinoma: four-year follow-up after treatment with cyproterone acetate.

Di Silverio F, Sciarra F, D'Eramo G, Tenaglia R.

Eur Urol. 1990;18(4):263-6.

PMID:
2149704
46.

Epidermal growth factor binding and steroid receptor content in human benign prostatic hyperplasia.

Lubrano C, Petrangeli E, Catizone A, Santonati A, Concolino G, Rombolá N, Frati L, Di Silverio F, Sciarra F.

J Steroid Biochem. 1989;34(1-6):499-504.

PMID:
2483222
47.

Anti-estrogens and aromatase inhibitors: tamoxifen and testolactone.

Sciarra F.

J Endocrinol Invest. 1988 Nov;11(10):755-62. Review. No abstract available.

PMID:
3068293
48.

[Effect of treatment with mepartricin on the plasma androgen and gonadotropin concentrations in subjects with benign prostatic hypertrophy].

Sciarra F, Bianchi P, Toscano V.

Minerva Urol Nefrol. 1988 Apr-Jun;40(2 Suppl):10-2. Italian. No abstract available.

PMID:
2460936
49.

Effects of two different medical treatments on dihydrotestosterone content and androgen receptors in human benign prostatic hyperplasia.

Petrangeli E, Sciarra F, Di Silverio F, Toscano V, Lubrano C, Conti C, Concolino G.

J Steroid Biochem. 1988;30(1-6):395-9.

PMID:
2455099
50.

[Etiopathogenesis of the polycystic ovary syndrome].

Sciarra F, Toscano V, Tosti-Croce C.

Minerva Endocrinol. 1987 Jul-Sep;12(3):183-90. Italian. No abstract available.

PMID:
3116379

Supplemental Content

Loading ...
Support Center